secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2026-02-23T23:59:59+00:00
Accession:  0000885725-26-000013
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific boosts buyback by $4B to $5B; appoints two new directors
--------------------------------------------------------------------------

- Board approved additional $4.0B stock repurchase authorization, total available now $5.0B.
- Board expanded from 10 to 12; appointed Catherine R. Smith (CFO of Starbucks) and Christophe P. Weber (CEO of Takeda).
- Smith and Weber will serve on audit and compensation committees; standard prorated compensation until 2026 annual meeting.
- Former directors John Sununu and Yoshiaki Fujimori will not stand for re-election at 2026 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572526000013/0000885725-26-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572526000013/bsx-20260218.htm
  HTML page:      https://secwatch.observer/filing/0000885725-26-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer